MAPK8 and fatty liver disease: In contrast, Singh et al. administered an antisense oligonucleotide to knock down JNK1 in a model of established hepatic steatosis and found that this was able to significantly reduce hepatic triglyceride content, whereas JNK2 knock down was not effective [100].